Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Goldberg

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cell|April 11, 2015
Immunoengineering: how nanotechnology can enhance cancer immunotherapyMichael S Goldberg
Methods (San Diego, Calif.)|February 14, 2013
siRNA delivery for the treatment of ovarian cancerMichael S Goldberg
Nature Reviews. Cancer|September 8, 2019
Improving cancer immunotherapy through nanotechnologyMichael S Goldberg
Nanomedicine (London, England)|March 22, 2017
Surface modulation of polymeric nanocarriers enhances the stability and delivery of proteins and small moleculesZohreh Amoozgar, Michael S Goldberg
Advanced Drug Delivery Reviews|October 5, 2014
Targeting myeloid cells using nanoparticles to improve cancer immunotherapyZohreh Amoozgar, Michael S Goldberg
The Journal of Experimental Medicine|January 25, 2012
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regressionMichael S Goldberg, Phillip A Sharp
Cancer Immunology, Immunotherapy : CII|December 10, 2015
Improving cancer immunotherapy with DNA methyltransferase inhibitorsMohammad H Saleh, Lei Wang, Michael S Goldberg
Molecular Cancer Therapeutics|May 13, 2015
Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian CancerMeghna Talekar, Qijun Ouyang, Michael S Goldberg, et al.
Cancer Discovery|June 21, 2017
DNA Damage and Repair Biomarkers of Immunotherapy ResponseKent W Mouw, Michael S Goldberg, Panagiotis A Konstantinopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cellsMichael S Goldberg, Deyin Xing, Yin Ren, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cell|April 11, 2015
Immunoengineering: how nanotechnology can enhance cancer immunotherapyMichael S Goldberg
Methods (San Diego, Calif.)|February 14, 2013
siRNA delivery for the treatment of ovarian cancerMichael S Goldberg
Nature Reviews. Cancer|September 8, 2019
Improving cancer immunotherapy through nanotechnologyMichael S Goldberg
Nanomedicine (London, England)|March 22, 2017
Surface modulation of polymeric nanocarriers enhances the stability and delivery of proteins and small moleculesZohreh Amoozgar, Michael S Goldberg
Advanced Drug Delivery Reviews|October 5, 2014
Targeting myeloid cells using nanoparticles to improve cancer immunotherapyZohreh Amoozgar, Michael S Goldberg
The Journal of Experimental Medicine|January 25, 2012
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regressionMichael S Goldberg, Phillip A Sharp
Cancer Immunology, Immunotherapy : CII|December 10, 2015
Improving cancer immunotherapy with DNA methyltransferase inhibitorsMohammad H Saleh, Lei Wang, Michael S Goldberg
Molecular Cancer Therapeutics|May 13, 2015
Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian CancerMeghna Talekar, Qijun Ouyang, Michael S Goldberg, et al.
Cancer Discovery|June 21, 2017
DNA Damage and Repair Biomarkers of Immunotherapy ResponseKent W Mouw, Michael S Goldberg, Panagiotis A Konstantinopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cellsMichael S Goldberg, Deyin Xing, Yin Ren, et al.
Pageof 3